Literature DB >> 15533761

Artemisinins: mechanisms of action and potential for resistance.

Sanjeev Krishna1, Anne-Catrin Uhlemann, Richard K Haynes.   

Abstract

Artemisinins form the most important class of antimalarial currently available, particularly because they are effective against parasites resistant to almost all the other classes. Their mechanism of action is controversial. Some aspects of this controversy are reviewed here. Whilst there is no clinical resistance yet identified to artemisinins, the potential to examine the relationship between polymorphisms in PfATP6 (a target of artemisinins) in multidrug resistant isolates of Plasmodium falciparum, is also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533761     DOI: 10.1016/j.drup.2004.07.001

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  47 in total

1.  Endoperoxide synthesis by photocatalytic aerobic [2 + 2 + 2] cycloadditions.

Authors:  Jonathan D Parrish; Michael A Ischay; Zhan Lu; Song Guo; Noël R Peters; Tehshik P Yoon
Journal:  Org Lett       Date:  2012-02-28       Impact factor: 6.005

Review 2.  Drug-resistant malaria.

Authors:  John E Hyde
Journal:  Trends Parasitol       Date:  2005-09-02

3.  Host candidate gene polymorphisms and associated clearance of P. falciparum amodiaquine and fansidar resistance mutants in children less than 5 years in Cameroon.

Authors:  Innocent Mbulli Ali; Marie-Solange Bebandue Evehe; Palmer Masumbe Netongo; Barbara Atogho-Tiedeu; Mbuh Akindeh-Nji; Honore Ngora; Irenee Kamogne Domkam; Mahamadou Diakite; Khan Baldip; Lisa Ranford-Cartwright; Patrice Nsangou Mimche; Tracey Lamb; Wilfred Fon Mbacham
Journal:  Pathog Glob Health       Date:  2014-11-12       Impact factor: 2.894

4.  Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.

Authors:  Matthew S Tucker; Tina Mutka; Kansas Sparks; Janus Patel; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7.

Authors:  Hanafy M Ismail; Victoria Barton; Matthew Phanchana; Sitthivut Charoensutthivarakul; Michael H L Wong; Janet Hemingway; Giancarlo A Biagini; Paul M O'Neill; Stephen A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 6.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

Review 7.  Drug-resistant malaria - an insight.

Authors:  John E Hyde
Journal:  FEBS J       Date:  2007-09       Impact factor: 5.542

8.  Defining the timing of action of antimalarial drugs against Plasmodium falciparum.

Authors:  Danny W Wilson; Christine Langer; Christopher D Goodman; Geoffrey I McFadden; James G Beeson
Journal:  Antimicrob Agents Chemother       Date:  2013-01-14       Impact factor: 5.191

9.  Artemisinin as a Chinese medicine, selectively induces apoptosis in pancreatic tumor cell line.

Authors:  Shokoofe Noori; Zuhair M Hassan; Vida Farsam
Journal:  Chin J Integr Med       Date:  2013-06-15       Impact factor: 1.978

10.  Evaluation of artemisinins for the treatment of acute myeloid leukemia.

Authors:  Christina D Drenberg; Jassada Buaboonnam; Shelley J Orwick; Shuiying Hu; Lie Li; Yiping Fan; Anang A Shelat; R Kiplin Guy; Jeffrey Rubnitz; Sharyn D Baker
Journal:  Cancer Chemother Pharmacol       Date:  2016-04-28       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.